Arovella Therapeutics (ASX:ALA) said that interim Chair Elizabeth Stoner has retired, effective Monday, according to a same-day Australian bourse filing.
The company will provide updates regarding the appointment of a new chair following the completion of a skills review, the filing added.
The company's shares rose 4% in recent Monday trade.